References
- 1 Campbell GD. Overview of community-acquired pneumonia. Prognosis and clinical features. Med Clin North Am 1994; 78: 1035–48.
- 2 Mandell LA, Marrie TJ, Grossman RF et al. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31: 383–421.
- 3 Bartlett JG, Dowell SF, Mandell LA et al. Practice guidelines for the management of community-acquired pneumonia. Clin Infect Dis 2000; 383: 347–82.
- 4 Marrie TJ, Peeling RW, Fine MJ, et al. Ambulatory patients with community acquired pneumonia: The frequency of atypical agents and clinical course. Am J Med 1996; 101: 508–515.
- 5 Langille DB, Yates L, Marrie TJ. Serological investigation of pneumonia as it presents to the physician’s office. Can J Infect Dis 1993; 4: 328–332.
- 6 Marrie TJ, Durant H, Yates L. Community acquired pneumonia requiring hospitalization: 5 year prospective study. Rev Infect Dis 1989; 11: 586–599.
- 7 Kauppinen MT, Herva E, Kujala P et al. The etiology of community acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis 1995; 172; 1330–1335.
- 8 Marston BJ, Plouffe JF, File TM Jr et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. Ann Intern Med 1997; 157: 1709–1718.
- 9 Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8: 451–61.
- 10 Gleason PP, Meehan TP, Fine JM et al. Associations between initial antimicrobial regimens and medical outcomes for elderly patients with pneumonia. Arch Intern Med 1999; 159: 2562–2572.
- 11 Shibl AM, Al Rasheed, Elbashier AM, Osoba AO. Penicillin resistant and intermediate Streptococcus pneumoniae in Saudi Arabia. J Chemother 2000; 12: 134–137.
- 12 Felmingham D, Washington J, The Alexander Project Group. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens: Findings of the Alexander Project 1992–1996. J Chemother 1999; 11: 5–21.
- 13 Syrjala H, Broas M, Suramo I et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 1998; 27: 258–63.
- 14 Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243–50.
- 15 Fine MJ, Medsger AR, Stone RA et al. The hospital discharge decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 1997; 157: 47–56.
- 16 Marrie TJ, Lau CY, Wheeler SL et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000; 283: 749–55.
- 17 Atlas SJ, Benzer TI, Borowsky LH, et al. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med 1998; 158: 1350–6.
- 18 Marras TK, Guterrez C, Chan CK. Applying a prediction rule to identify low-risk patients with community-acquired pneumonia. Chest 2000; 118: 1339–43.
- 19 Marras TK, Lee-Pack L, Jamieson L, Chan CK. Guidelines adherence and clinical outcomes in community-acquired pneumonia: are new guidelines improving outcomes? Chest 2000; 118: 111S.
- 20 Mandell LA, Niederman M. The Canadian Community Acquired Pneumonia Consensus Conference Group. Antimicrobial treatment of community acquired pneumonia in adults: A conference report. Can J Infect Dis 1993; 4: 25–28.